基于证据的包对剖腹产相关的手术部位感染的影响:一项随机临床试验
Aditya Gan1, Romana Khursheed1, Mahadevi Savanur1
1Department of Obstetrics and Gynecology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research, Belagavi, Karnataka 590009, India.
概括
与标准护理相比,一个基于证据的包裹显著减少了剖腹产手术部位感染 (SSI) 的一半. 这种干预提供了一种具有成本效益的策略,以改善剖腹产后患者的治疗结果.
科学领域:
- 产科和妇科 产科和妇科
- 预防传染病 预防传染病
- 手术场所感染控制手术场所感染控制
背景情况:
- 剖腹产 (CS) 是全球常见的一种手术手术.
- 手术部位感染 (SSIs) 是CS后的重大并发症,导致发病率,死亡率和医疗保健成本增加.
- 对CS的标准外科手术期间护理协议可能不足以最大限度地降低SSI风险.
研究的目的:
- 评估基于证据的外科手术包在减少与CS相关的SSI发病率的有效性,与标准的常规护理相比.
- 确定多组分干预是否可以降低剖腹产妇女SSI的比率.
主要方法:
- 一个单中心,并行,随机的临床试验与320名接受CS的妇女进行.
- 参与者被随机分配到接受基于证据的外科手术包或接受标准术后护理的对照组的干预组.
- 主要结局是产后六周内SSI的发生率,统计分析使用P < 0.05.
主要成果:
- 在控制组和干预组分别分析了144名和143名参与者.
- 与对照组 (19.4%) 相比,干预组 (9.8%) 的SSI发病率明显较低 (P = 0.02).
- 在这两组中,甲素耐药黄金葡萄球菌被确定为导致SSI的最常见病原体.
结论:
- 与标准护理相比,基于证据的外科手术捆绑有效地将CS相关SSI的发病率减半.
- 建议在常规外科手术期间实践中实施该包,以减少CS相关的感染并改善患者的治疗结果.
- 这种干预有可能降低与剖腹产相关的医疗保健成本.
相关概念视频
Healthcare Associated Infections II: Preventive Measures
4.4K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.4K
Nursing Clinical Information System
1.3K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.3K
Factors Affecting the Risk of Infection
14.1K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
500
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
500
Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K


